Grant opportunity
UKRI Translation: MRC Impact Acceleration Awards 2026
MRC is supporting single-step translational projects that de-risk development of new or repurposed medicines, devices, diagnostics and other medical products.
- Funder
- Medical Research Council (MRC)
- Applications close 11 November 2026 at 16:00 UK time
- Applications close 11 November 2026 at 16:00 UK time: Nov 11, 2026
- Award
- GBP 50,000 to GBP 300,000
- Applicant
- Project leads based at an MRC-eligible UK research organisation, including eligible NHS organisations where available in the UKRI Funding Service.
- Discipline
- Health and Biomedical Sciences
- Region
- United Kingdom / Global Health
- Posted
- Jul 16, 2026
Call summary
Overview
The MRC Impact Acceleration Awards bridge smaller impact acceleration support and larger proof-of-concept funding by supporting one focused, high-risk development step.
Who can apply
Applicants must be based at a UK research organisation eligible for MRC funding. The lead research organisation submits the application through the UKRI Funding Service.
What it supports
- Academically led translational development work for medicines, medical devices, diagnostics or other medical products.
- Projects should generate critical data to de-risk onward progression or determine whether a product development route should stop.
- Themes include precision prevention, early diagnosis, advanced treatments, outcome monitoring and disease management technologies.
Funding and duration
- Awards range from GBP 50,000 to GBP 300,000.
- Projects may address UK healthcare needs and global health issues where within MRC remit.
Applications close 11 November 2026 at 16:00 UK time
Applications close 11 November 2026 at 16:00 UK time: Nov 11, 2026
How to apply
Use the Start application route on the official UKRI Funding Finder page and submit through the UKRI Funding Service by the stated deadline.
Call details
Source-based overview
This open MRC opportunity supports single-step packages of translational development work. It is intended for projects that have a clear health or clinical need, a defined product or technology route, prior supporting evidence, and a specific development step that can produce decision-making data for onward progression.
Eligibility
Applicants must be based at a UK research organisation eligible for MRC funding. The lead research organisation submits the application through the UKRI Funding Service.
Funding and benefits
Awards range from GBP 50,000 to GBP 300,000.
Projects may address UK healthcare needs and global health issues where within MRC remit.
Themes and supported activities
Academically led translational development work for medicines, medical devices, diagnostics or other medical products.
Projects should generate critical data to de-risk onward progression or determine whether a product development route should stop.
Themes include precision prevention, early diagnosis, advanced treatments, outcome monitoring and disease management technologies.
Deadline and timeline
Applications close 11 November 2026 at 16:00 UK time: Applications close 11 November 2026 at 16:00 UK time: Nov 11, 2026.
Applicants should confirm the exact deadline time, time zone, required documents, portal steps and any institutional approvals on the official call page before submitting.
How to apply
Use the Start application route on the official UKRI Funding Finder page and submit through the UKRI Funding Service by the stated deadline.
Before applying, check eligibility rules, budgets, attachments, page limits, partner requirements, cost-share conditions and whether the opportunity uses an expression of interest, full proposal, registration or nomination stage.